Page 34 - ASPIRE AUGUST 2022 Vol 7 Issue 3
P. 34
Trust matters
when optimizing
your patients’ journey
50% more women achieved target oocyte yield (n=8–14) with biomarker-driven starting doses of GONAL-f® than with fixed, age-based initial doses1
Inspire confidence
1. Allegra A, et al. Reprod Biomed Online 2017;34(4):429–438) GBPMLR/GON/0000/0000
Date of approval: March 2022
Tao Lau IVF support group
Tao Lau is feeling nervous but positive! 🤞
Holding my breath... #IVFwarrior #gonalf #follicles
82
